Capricor Therapeutics Inc
NASDAQ:CAPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
Tronox Holdings PLC
NYSE:TROX
|
US |
|
Arhaus Inc
NASDAQ:ARHS
|
US |
|
Societe Generale SA
PAR:GLE
|
FR |
|
Daito Trust Construction Co Ltd
OTC:DIFTY
|
JP |
|
N
|
Nike Inc
XBER:NKE
|
US |
|
Prysmian SpA
MIL:PRY
|
IT |
|
N
|
Nike Inc
XMUN:NKE
|
US |
|
Breville Group Ltd
ASX:BRG
|
AU |
|
Minerva Neurosciences Inc
NASDAQ:NERV
|
US |
|
Dynamatic Technologies Ltd
NSE:DYNAMATECH
|
IN |
|
H
|
Hershey Co
XHAM:HSY
|
US |
|
U
|
Unilever PLC
DUS:UNVB
|
UK |
|
T
|
Tomocube Inc
KOSDAQ:475960
|
KR |
|
Chemed Corp
NYSE:CHE
|
US |
|
Polycab India Ltd
NSE:POLYCAB
|
IN |
|
B
|
Bloom Energy Corp
SWB:1ZB
|
US |
|
S
|
Simcorp A/S
CSE:SIM
|
DK |
|
RF Acquisition Corp II
NASDAQ:RFAI
|
SG |
|
Investigator Resources Ltd
ASX:IVR
|
AU |
|
Just Kitchen Holdings Corp
XTSX:JK
|
CA |
|
Quadient SA
F:NEQ
|
FR |
|
L
|
Legrand SA
DUS:LRC
|
FR |
|
V
|
Volkswagen AG
F:VOW
|
DE |
Wall St Price Targets
CAPR Price Targets Summary
Capricor Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CAPR is 55.76 USD with a low forecast of 43.43 USD and a high forecast of 66.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CAPR's stock price target?
Price Target
55.76
USD
According to Wall Street analysts, the average 1-year price target for
CAPR is 55.76 USD with a low forecast of 43.43 USD and a high forecast of 66.15 USD.